Documents with a large file size are provided in a .zip file and will need to be uncompressed after download.
File Name | Date Produced | File Size | Link |
---|
125742_S1_M1_356h.pdfMarch 1, 2022714 KB
125742_S1_M1_3674.pdfMarch 1, 20225 MB125742_S1_M1_cover.pdfMarch 1, 20221 MB
125742_S1_M1_debarment.pdfMarch 1, 2022656 KB
125742_S1_M1_exclusivity-claim.pdfMarch 1, 2022616 KB
125742_S1_M1_fast-track-designation.pdfMarch 1, 2022649 KB
125742_S1_M1_financial-cert-3454.pdfMarch 1, 20223 MB
125742_S1_M1_financial-cert-bias.pdfMarch 1, 2022696 KB
125742_S1_M1_ipsp-agreed-letter.pdfMarch 1, 2022658 KB
125742_S1_M1_priority-review-request.pdfMarch 24, 20222 MB
125742_S1_M1_priority-review-request.pdfMarch 1, 20222 MB
125742_S1_M1_trans-of-oblig.pdfMarch 1, 2022717 KB
125742_S1_M1_us-agent-authorization.pdfMarch 1, 20221 MB
125742_S1_M1_userfee.pdfMarch 1, 2022628 KB
125742_S1_M1_waiver-req-designated-suffix.pdfMarch 1, 20223 MB
125742_S1_M2_22_introduction.pdfMarch 1, 2022670 KB
125742_S1_M2_24_nonclinical-overview.pdfMarch 1, 20222 MB
125742_S1_M2_26_pharmkin-tabulated-summary.pdfMarch 1, 20221 MB
125742_S1_M2_26_pharmkin-written-summary.pdfMarch 1, 20221 MB
125742_S1_M2_27_literature-references.pdfMarch 1, 20222 MB
125742_S1_M2_27_synopses-indiv-studies.pdfMarch 1, 20222 MB
125742_S1_M4_4223_185350.pdfMarch 1, 20221 MB
125742_S1_M4_4223_R-20-0072.pdfMarch 1, 20225 MB
125742_S1_M5_5351_bnt162 01 interim3 adverse events.pdfMay 2, 20227 MB
125742_S1_M5_5351_bnt162 01 interim3 compliance.pdfMay 2, 20227 MB
125742_S1_M5_5351_bnt162 01 interim3 demographics.pdfMay 2, 20222 MB
125742_S1_M5_5351_bnt162 01 interim3 discontinued patients.pdfMay 2, 20222 MB
125742_S1_M5_5351_bnt162 01 interim3 excluded patients.pdfMay 2, 20222 MB
125742_S1_M5_5351_bnt162 01 interim3 iec irb.pdfMay 2, 20221 MB
125742_S1_M5_5351_bnt162 01 interim3 invest signature.pdfMay 2, 2022634 KB
125742_S1_M5_5351_bnt162 01 interim3 investigators.pdfMay 2, 20226 MB
125742_S1_M5_5351_bnt162 01 interim3 lab measurements.pdfMay 2, 202291 MB
125742_S1_M5_5351_bnt162 01 interim3 notes for reader.pdfMay 2, 20221 MB
125742_S1_M5_5351_bnt162 01 interim3 patient batches.pdfMay 2, 20223 MB
125742_S1_M5_5351_bnt162 01 interim3 protocol deviations.pdfMay 2, 20221 MB
125742_S1_M5_5351_bnt162 01 interim3 protocol.pdfMay 2, 202210 MB
125742_S1_M5_5351_bnt162 01 interim3 report body.pdfMay 2, 202242 MB
125742_S1_M5_5351_bnt162 01 interim3 sample crf.pdfMay 2, 20229 MB
125742_S1_M5_5351_bnt162 01 interim3 sap.pdfMay 2, 20223 MB
125742_S1_M5_5351_bnt162 01 interim3 sponsor personnel list.pdfMay 2, 20222 MB
125742_S1_M5_5351_bnt162 01 interim3 sponsor signature.pdfMay 2, 20222 MB
125742_S1_M5_5351_bnt162 01 interim3 synopsis.pdfMay 2, 20224 MB
125742_S1_M5_5351_bnt162 01_10010.pdfMay 2, 20221 MB
125742_S1_M5_5351_bnt162 01_10075.pdfMay 2, 20222 MB
125742_S1_M5_5351_bnt162 01_20116.pdfMay 2, 20222 MB
125742_S1_M5_5351_bnt162 01_20215.pdfMay 2, 20222 MB
125742_S1_M5_5351_bnt162 01_20242.pdfMay 2, 20222 MB
125742_S1_M5_5351_c4591001 interim mth6 randomization sensitive.pdfMay 2, 202265 MB
125742_S1_M5_5351_c4591001 interim mth6 sample crf.pdfMay 2, 20225 MB
125742_S1_M5_5351_c4591001 interim mth6 sponsor signature.pdfMay 2, 202212 MB
125742_S1_M5_5351_c4591001-ad-hoc-label-tables.pdfMarch 1, 2022889 KB
125742_S1_M5_5351_c4591001-fa-interim-audit-certificates.pdfApril 1, 2022869 KB
125742_S1_M5_5351_c4591001-fa-interim-compliance-sensitive.pdfMarch 1, 20221 MB
125742_S1_M5_5351_c4591001-fa-interim-compliance.pdfMarch 1, 20222 MB
125742_S1_M5_5351_c4591001-fa-interim-demographics.pdfApril 1, 202228 MB
125742_S1_M5_5351_c4591001-fa-interim-efficacy-response.pdfMarch 1, 20222 MB
125742_S1_M5_5351_c4591001-fa-interim-errata.pdfMarch 1, 20222 MB
125742_S1_M5_5351_c4591001-fa-interim-excluded-patients-sensitive.pdfMarch 1, 202216 MB
125742_S1_M5_5351_c4591001-fa-interim-excluded-patients.pdfMarch 1, 20222 MB
125742_S1_M5_5351_c4591001-fa-interim-iec-irb-consent-form.pdfApril 1, 20228 MB
125742_S1_M5_5351_c4591001-fa-interim-invest-signature.pdfApril 1, 2022677 KB
125742_S1_M5_5351_c4591001-fa-interim-lab-measurements-sensitive.pdfMarch 1, 20225 MB
125742_S1_M5_5351_c4591001-fa-interim-lab-measurements.pdfMarch 1, 202212 MB
125742_S1_M5_5351_c4591001-fa-interim-oversight-committees.pdfMarch 1, 20222 MB
125742_S1_M5_5351_c4591001-fa-interim-protocol-deviations.pdfApril 1, 20221 MB
125742_S1_M5_5351_c4591001-fa-interim-protocol.pdfMarch 1, 202231 MB
125742_S1_M5_5351_c4591001-fa-interim-publications.pdfApril 1, 202210 MB
125742_S1_M5_5351_c4591001-fa-interim-randomization-sensitive.pdfApril 1, 202259 MB
125742_S1_M5_5351_c4591001-fa-interim-randomization.pdfApril 1, 20222 MB
125742_S1_M5_5351_c4591001-fa-interim-sample-crf.pdfApril 1, 20225 MB
125742_S1_M5_5351_c4591001-fa-interim-sponsor-signature.pdfApril 1, 20222 MB
125742_S1_M5_5351_c4591001-interim-mth6-adverse-events-sensitive.pdfApril 1, 20221 MB
125742_S1_M5_5351_c4591001-interim-mth6-audit-certificates.pdfApril 1, 20221 MB
125742_S1_M5_5351_c4591001-interim-mth6-demographics.pdfApril 1, 202228 MB
125742_S1_M5_5351_c4591001-interim-mth6-invest-signature.pdfApril 1, 20221 MB
125742_S1_M5_5351_c4591001-interim-mth6-oversight-committees.pdfMarch 1, 202213 MB
125742_S1_M5_5351_c4591001-interim-mth6-protocol.pdfMarch 1, 202237 MB
125742_S1_M5_bnt162 01 A adrg.pdfMay 2, 2022891 KB
125742_S1_M5_bnt162 01 S acrf.pdfMay 2, 20221 MB
125742_S1_M5_bnt162 01 S csdrg.pdfMay 2, 20221 MB
125742_S1_M5_c4591001 S acrf.pdfMay 2, 20223 MB
125742_S1_M5_c4591001 S csdrg.pdfMay 2, 20221 MB
125742_S1_M5_c4591001 S Supp acrf.pdfMay 2, 20223 MB
125742_S1_M5_c4591001-A-201114-hiv-preferred-terms.pdfMarch 1, 2022602 KB
125742_S1_M5_c4591001-A-adrg.pdfMarch 1, 20222 MB
125742_S1_M5_c4591001-A-bmi-12-15-scale.pdfMarch 1, 2022627 KB
125742_S1_M5_c4591001-A-c4591001-phase-1-subjects-from-dmw.pdfMarch 1, 2022634 KB
125742_S1_M5_c4591001-A-c4591001-subject-list-for-12-25-immuno-analysis-27jan2021.pdfMarch 1, 2022620 KB
125742_S1_M5_c4591001-A-comorbidity-categories.pdfMarch 1, 2022637 KB
125742_S1_M5_c4591001-A-first-c4591001-360-participants-enrolled-v1-13aug20-update.pdfMarch 1, 2022607 KB
125742_S1_M5_c4591001-A-newlist-c4591001-6k-participants-enrolled-v3-17sep2020.pdfMarch 1, 2022846 KB
125742_S1_M5_c4591001-A-report-cci-aids-hiv.pdfMarch 1, 2022629 KB
125742_S1_M5_c4591001-A-report-cci-any-malignancy.pdfMarch 1, 2022670 KB
125742_S1_M5_c4591001-A-report-cci-cerebrovascular.pdfMarch 1, 2022632 KB
125742_S1_M5_c4591001-A-report-cci-chf.pdfMarch 1, 2022628 KB
125742_S1_M5_c4591001-A-report-cci-dementia.pdfMarch 1, 2022626 KB
125742_S1_M5_c4591001-A-report-cci-diabetes-with-comp.pdfMarch 1, 2022626 KB
125742_S1_M5_c4591001-A-report-cci-diabetes-without-comp.pdfMarch 1, 2022627 KB
125742_S1_M5_c4591001-A-report-cci-hemiplegia.pdfMarch 1, 2022626 KB
125742_S1_M5_c4591001-A-report-cci-leukemia.pdfMarch 1, 2022631 KB